Log in
RegisterClinical endpoint studies [Design Issues]
Hi myy,
Ivermectin can be measured in plasma, so I don't think it is an obvious candidate for a PD-study. As Dr_Dan says, why not just forget about this current formulation; just stop the show now or alternatively re-formulate.
If you seek scientific advice you may get green light to do PD, though. It will be terrible in every sense: Expensive, time-consuming, complicated, with weird statistics, and possibly involving infected patients with all what that entails with ethical issues and what not. You don't want to do it. Trust me.
❝ The antiparasitc drug ivermectin and it is for the EU.
Ivermectin can be measured in plasma, so I don't think it is an obvious candidate for a PD-study. As Dr_Dan says, why not just forget about this current formulation; just stop the show now or alternatively re-formulate.
If you seek scientific advice you may get green light to do PD, though. It will be terrible in every sense: Expensive, time-consuming, complicated, with weird statistics, and possibly involving infected patients with all what that entails with ethical issues and what not. You don't want to do it. Trust me.
—
Pass or fail!
ElMaestro
Pass or fail!
ElMaestro
Complete thread:
- Clinical endpoint studies myy 2014-04-17 15:40
![[Mix]](https://static.bebac.at/img/mix.png "open in Mix view")
- Clinical endpoint studies Dr_Dan 2014-04-17 18:15
- Clinical endpoint studies ElMaestro 2014-04-19 13:16
- Clinical endpoint studies myy 2014-04-19 13:43
- Clinical endpoint studiesElMaestro 2014-04-19 15:12
- Clinical endpoint studies myy 2014-04-19 13:43
Ing. Helmut Schütz